Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation

Sofie Snipstad, Einar Sulheim, Catharina de Lange Davies, Chrit Moonen, Gert Storm, Fabian Kiessling, Ruth Schmid (Corresponding Author), Twan Lammers (Corresponding Author)

Research output: Contribution to journalReview articleAcademicpeer-review

3 Citations (Scopus)

Abstract

Introduction: Ultrasound in combination with microbubbles can make cells and tissues more accessible for drugs, thereby achieving improved therapeutic outcomes. In this review, we introduce the term ‘sonopermeation’, covering mechanisms such as pore formation (traditional sonoporation), as well as the opening of intercellular junctions, stimulated endocytosis/transcytosis, improved blood vessel perfusion and changes in the (tumor) microenvironment. Sonopermeation has gained a lot of interest in recent years, especially for delivering drugs through the otherwise impermeable blood-brain barrier, but also to tumors. Areas covered: In this review, we summarize various in vitro assays and in vivo setups that have been employed to unravel the fundamental mechanisms involved in ultrasound-enhanced drug delivery, as well as clinical trials that are ongoing in patients with brain, pancreatic, liver and breast cancer. We summarize the basic principles of sonopermeation, describe recent findings obtained in (pre-) clinical trials, and discuss future directions. Expert Opinion: We suggest that an improved mechanistic understanding, and microbubbles and ultrasound equipment specialized for drug delivery (and not for imaging) are key aspects to create more effective treatment regimens by sonopermeation. Real-time feedback and tools to predict therapeutic outcome and which tumors/patients will benefit from sonopermeation-based interventions will be important to promote clinical translation.

Original languageEnglish
Pages (from-to)1249-1261
Number of pages13
JournalExpert opinion on drug delivery
Volume15
Issue number12
DOIs
Publication statusPublished - 2 Dec 2018

Fingerprint

Microbubbles
Pharmaceutical Preparations
Neoplasms
Clinical Trials
Transcytosis
Intercellular Junctions
Tumor Microenvironment
Expert Testimony
Liver Neoplasms
Endocytosis
Blood-Brain Barrier
Pancreatic Neoplasms
Brain Neoplasms
Therapeutics
Breast Neoplasms
Equipment and Supplies
In Vitro Techniques
Direction compound

Keywords

  • blood-brain barrier
  • cancer
  • drug delivery
  • drug targeting
  • microbubbles
  • nanomedicine
  • Sonopermeation
  • sonoporation
  • ultrasound

Cite this

Snipstad, Sofie ; Sulheim, Einar ; de Lange Davies, Catharina ; Moonen, Chrit ; Storm, Gert ; Kiessling, Fabian ; Schmid, Ruth ; Lammers, Twan. / Sonopermeation to improve drug delivery to tumors : from fundamental understanding to clinical translation. In: Expert opinion on drug delivery. 2018 ; Vol. 15, No. 12. pp. 1249-1261.
@article{5e6417645df14cdcbc2a083bbe4aeabe,
title = "Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation",
abstract = "Introduction: Ultrasound in combination with microbubbles can make cells and tissues more accessible for drugs, thereby achieving improved therapeutic outcomes. In this review, we introduce the term ‘sonopermeation’, covering mechanisms such as pore formation (traditional sonoporation), as well as the opening of intercellular junctions, stimulated endocytosis/transcytosis, improved blood vessel perfusion and changes in the (tumor) microenvironment. Sonopermeation has gained a lot of interest in recent years, especially for delivering drugs through the otherwise impermeable blood-brain barrier, but also to tumors. Areas covered: In this review, we summarize various in vitro assays and in vivo setups that have been employed to unravel the fundamental mechanisms involved in ultrasound-enhanced drug delivery, as well as clinical trials that are ongoing in patients with brain, pancreatic, liver and breast cancer. We summarize the basic principles of sonopermeation, describe recent findings obtained in (pre-) clinical trials, and discuss future directions. Expert Opinion: We suggest that an improved mechanistic understanding, and microbubbles and ultrasound equipment specialized for drug delivery (and not for imaging) are key aspects to create more effective treatment regimens by sonopermeation. Real-time feedback and tools to predict therapeutic outcome and which tumors/patients will benefit from sonopermeation-based interventions will be important to promote clinical translation.",
keywords = "blood-brain barrier, cancer, drug delivery, drug targeting, microbubbles, nanomedicine, Sonopermeation, sonoporation, ultrasound",
author = "Sofie Snipstad and Einar Sulheim and {de Lange Davies}, Catharina and Chrit Moonen and Gert Storm and Fabian Kiessling and Ruth Schmid and Twan Lammers",
year = "2018",
month = "12",
day = "2",
doi = "10.1080/17425247.2018.1547279",
language = "English",
volume = "15",
pages = "1249--1261",
journal = "Expert opinion on drug delivery",
issn = "1742-5247",
publisher = "Taylor & Francis",
number = "12",

}

Sonopermeation to improve drug delivery to tumors : from fundamental understanding to clinical translation. / Snipstad, Sofie; Sulheim, Einar; de Lange Davies, Catharina; Moonen, Chrit; Storm, Gert; Kiessling, Fabian; Schmid, Ruth (Corresponding Author); Lammers, Twan (Corresponding Author).

In: Expert opinion on drug delivery, Vol. 15, No. 12, 02.12.2018, p. 1249-1261.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Sonopermeation to improve drug delivery to tumors

T2 - from fundamental understanding to clinical translation

AU - Snipstad, Sofie

AU - Sulheim, Einar

AU - de Lange Davies, Catharina

AU - Moonen, Chrit

AU - Storm, Gert

AU - Kiessling, Fabian

AU - Schmid, Ruth

AU - Lammers, Twan

PY - 2018/12/2

Y1 - 2018/12/2

N2 - Introduction: Ultrasound in combination with microbubbles can make cells and tissues more accessible for drugs, thereby achieving improved therapeutic outcomes. In this review, we introduce the term ‘sonopermeation’, covering mechanisms such as pore formation (traditional sonoporation), as well as the opening of intercellular junctions, stimulated endocytosis/transcytosis, improved blood vessel perfusion and changes in the (tumor) microenvironment. Sonopermeation has gained a lot of interest in recent years, especially for delivering drugs through the otherwise impermeable blood-brain barrier, but also to tumors. Areas covered: In this review, we summarize various in vitro assays and in vivo setups that have been employed to unravel the fundamental mechanisms involved in ultrasound-enhanced drug delivery, as well as clinical trials that are ongoing in patients with brain, pancreatic, liver and breast cancer. We summarize the basic principles of sonopermeation, describe recent findings obtained in (pre-) clinical trials, and discuss future directions. Expert Opinion: We suggest that an improved mechanistic understanding, and microbubbles and ultrasound equipment specialized for drug delivery (and not for imaging) are key aspects to create more effective treatment regimens by sonopermeation. Real-time feedback and tools to predict therapeutic outcome and which tumors/patients will benefit from sonopermeation-based interventions will be important to promote clinical translation.

AB - Introduction: Ultrasound in combination with microbubbles can make cells and tissues more accessible for drugs, thereby achieving improved therapeutic outcomes. In this review, we introduce the term ‘sonopermeation’, covering mechanisms such as pore formation (traditional sonoporation), as well as the opening of intercellular junctions, stimulated endocytosis/transcytosis, improved blood vessel perfusion and changes in the (tumor) microenvironment. Sonopermeation has gained a lot of interest in recent years, especially for delivering drugs through the otherwise impermeable blood-brain barrier, but also to tumors. Areas covered: In this review, we summarize various in vitro assays and in vivo setups that have been employed to unravel the fundamental mechanisms involved in ultrasound-enhanced drug delivery, as well as clinical trials that are ongoing in patients with brain, pancreatic, liver and breast cancer. We summarize the basic principles of sonopermeation, describe recent findings obtained in (pre-) clinical trials, and discuss future directions. Expert Opinion: We suggest that an improved mechanistic understanding, and microbubbles and ultrasound equipment specialized for drug delivery (and not for imaging) are key aspects to create more effective treatment regimens by sonopermeation. Real-time feedback and tools to predict therapeutic outcome and which tumors/patients will benefit from sonopermeation-based interventions will be important to promote clinical translation.

KW - blood-brain barrier

KW - cancer

KW - drug delivery

KW - drug targeting

KW - microbubbles

KW - nanomedicine

KW - Sonopermeation

KW - sonoporation

KW - ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85058671633&partnerID=8YFLogxK

U2 - 10.1080/17425247.2018.1547279

DO - 10.1080/17425247.2018.1547279

M3 - Review article

VL - 15

SP - 1249

EP - 1261

JO - Expert opinion on drug delivery

JF - Expert opinion on drug delivery

SN - 1742-5247

IS - 12

ER -